@article{4cb067e88bff440ba93e5bd0c19f479d,
title = "Better understanding the neurobiology of primary lateral sclerosis",
abstract = "Primary lateral sclerosis (PLS) is a rare neurodegenerative disease characterized by progressive degeneration of upper motor neurons (UMNs). Recent studies shed new light onto the cellular events that are particularly important for UMN maintenance including intracellular trafficking, mitochondrial energy homeostasis and lipid metabolism. This review summarizes these advances including the role of Alsin as a gene linked to atypical forms of juvenile PLS, and discusses wider aspects of cellular pathology that have been observed in adult forms of PLS. The review further discusses the prospects of new transgenic upper motor neuron reporter mice, human stem cell-derived UMN cultures, cerebral organoids and non-human primates as future model systems to better understand and ultimately treat PLS.",
keywords = "ALS2, Alsin, Betz cell, Golgi apparatus, bioenergetics, corticospinal motor neuron, endosomes, membrane lipids, mitochondria, primary lateral sclerosis, upper motor neuron",
author = "Ozdinler, {P. Hande} and Mukesh Gautam and Oge Gozutok and Csaba Konrad and Giovanni Manfredi and {Area Gomez}, Estela and Hiroshi Mitsumoto and Erb, {Marcella L.} and Zheng Tian and Georg Haase",
note = "Funding Information: PHO is supported by NIH-NIA [grant RO1AG061708]. GM is funded by NIH [grant R01NS093872] and the ALS Association. CK is funded by the Muscular Disease Association. GH is supported by Agence Nationale pour la Recherche (ANR) in the frame of an eRARE3 call (grant Repetomics), the Association Fran{\c c}aise contre les Myopathies (AFM) and the F{\'e}d{\'e}ration pour la Recherche sur le Cerveau (FRC). The UCSD Light Microscopy Core is funded by NINDS NS047101. We thank Drs. Giorgia Quadrato (USC, Los Angeles, USA) and Vincenzo Silani (Dept. Neurology, Milan University, Italy) for helpful comments and suggestions, the Second International PLS Conference, Philadelphia, 2019, was supported by the National Institutes of Neurological Disorders and Stroke (NINDS), the Spastic Paraplegia Foundation (SPF), the Motor Neuron Disease Association (MNDA), The ALS Association, Mr. David Marren and his family, Mitsubishi-Tanabe Pharma, and Biogen. The supplement received financial support from Biogen and SPF. We are grateful to the PLS patients who attended the conference and actively participated in the discussions. Funding Information: We thank Drs. Giorgia Quadrato (USC, Los Angeles, USA) and Vincenzo Silani (Dept. Neurology, Milan University, Italy) for helpful comments and suggestions, the Second International PLS Conference, Philadelphia, 2019, was supported by the National Institutes of Neurological Disorders and Stroke (NINDS), the Spastic Paraplegia Foundation (SPF), the Motor Neuron Disease Association (MNDA), The ALS Association, Mr. David Marren and his family, Mitsubishi-Tanabe Pharma, and Biogen. The supplement received financial support from Biogen and SPF. We are grateful to the PLS patients who attended the conference and actively participated in the discussions. Publisher Copyright: {\textcopyright} 2020 World Federation of Neurology on behalf of the Research Group on Motor Neuron Diseases.",
year = "2020",
doi = "10.1080/21678421.2020.1837175",
language = "English (US)",
volume = "21",
pages = "35--46",
journal = "Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders",
issn = "2167-8421",
publisher = "Informa Healthcare",
number = "S1",
}
